Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib)

Clinical trial NCT06498167 · UNKNOWN

Trial details

NCT number: NCT06498167
Sponsor: Universidade do Porto
Status: UNKNOWN
Study type: OBSERVATIONAL

Inflammatory Disease Drug Side Effect Drug Use Adverse Drug Event Adverse Drug Reaction Safety Issues

Start date: 2024-07-01
Primary completion: 2024-10-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.